MONTVALE, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its second quarter 2006 financial results on Wednesday, August 9, 2006, before the U.S. financial markets open. Management will provide a Company update and discuss the second quarter results during a conference call on Wednesday, August 9, 2006, at 9:00 a.m. EDT.
Investors and other interested parties may access the call as follows: Date: Wednesday, August 9, 2006 Time: 9:00 a.m. EDT Telephone (U.S.): 866.800.8649 Telephone (international): 617.614.2703 Participant Passcode: 94294745 Webcast: http://www.memorypharma.com under the “Investors” section
An audio replay of the conference call will be available from 11:00 a.m. EDT on Wednesday, August 9, 2006, until Wednesday, August 16, 2006. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 63605504. An audio replay of the conference call will also be available under the “Investors” section of the Company’s website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;or Laura Perry of Stern Investor Relations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
